InvivoChem Cat #:V13773CAS #:92478-27-8Purity >=98%Description: Morinidazole was approved by China Food and Drug Administration (CFDA) on February 24, 2014. Morinidazole is a nitroimidazoles antibiotic used to treat bacterial infections including appendicitis and pelvic inflammatory disease. Morinidazole is a nitroimidazoles antibiotic indicated for the treatment of bacterial infections including appendicitis and pelvic inflammatory disease (PID) caused by anaerobic bacteria.
References: Pang X, Zhang Y, Gao R, Zhong K, Zhong D, Chen X. Effects of rifampin and ketoconazole on pharmacokinetics of morinidazole in healthy chinese subjects. Antimicrob Agents Chemother. 2014 Oct; 58(10):5987-93. doi: 10.1128/AAC.03382-14. Epub 2014 Jul 28. PubMed PMID: 25070100; PubMed Central PMCID: PMC4187946.